Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH)


Phase 3 Results N/A

Summary of Purpose

The IMASH trial is a simple, randomized, double-blinded, placebo-controlled, multi-center trial to answer the question: "Does intravenous magnesium sulfate improve clinical outcome after aneurysmal subarachnoid hemorrhage?"

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 December 2009.

1 Jun 2002 26 Jul 2005 1 Dec 2008 1 Jun 2009 1 Jul 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


  • George KC Wong, FRCS(SN) Department of Surgery Chinese University of Hong Kong Hong Kong, 852, China Phone: +852 2632 2624